Evoke Pharma, Inc. (EVOK)

Evoke Pharma Revenue

Evoke Pharma had revenue of $6.11M in the twelve months ending March 31, 2024, with 110.49% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.74M with 114.15% year-over-year growth. In the year 2023, Evoke Pharma had annual revenue of $5.18M with 106.51% growth.

• Revenue (ttm): $6.11M
• Revenue Growth: +110.49%
• P/S Ratio: 0.75
• Revenue / Employee: $1,526,428
• Employees: 4
• Market Cap: 4.57M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.18M	2.67M	106.51%
Dec 31, 2022	2.51M	890.57K	55.04%
Dec 31, 2021	1.62M	1.60M	6,929.00%
Dec 31, 2020	23.02K	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.